Anne Koralova is a Cross Autoimmunity Prevention Symposium Attendee

Dr. Koralova advances primary prevention strategies in type 1 diabetes (T1D) through stewardship of a research portfolio focused on identifying risk, intercepting early autoimmunity, and stopping disease before clinical onset. With experience spanning translational science, therapeutics strategy and biotechnology, she supports initiatives that accelerate prediction, prevention and durable immune intervention in T1D.